PACS · Pacs Group, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.42B | - | $1.34B | $1.31B | $1.28B | - | $1.03B | $981.85M | $934.72M | - |
| Cost of Revenue | - | - | - | - | - | - | $849.60M | $590.82M | $735.99M | - |
| Gross Profit | - | - | - | - | - | - | $176.71M | $391.03M | $198.73M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $112.31M | - | $102.53M | $100.33M | $98.72M | - | $70.59M | $62.70M | $46.91M | - |
| Total Operating Expenses | $1.30B | - | $1.26B | $1.23B | $1.23B | - | $1.00B | $981.14M | $854.76M | - |
| D&A | - | - | - | - | - | - | $6.36M | $6.16M | $7.90M | - |
| Operating Income | $120.03M | - | $86.27M | $80.50M | $48.14M | - | $36.40M | $710.0K | $79.96M | - |
| Interest Expense | $6.42M | - | $8.53M | $4.35M | $6.90M | - | $9.03M | $9.19M | - | - |
| Income Tax | $33.07M | - | $23.97M | $27.65M | $14.35M | - | $7.47M | $10.37M | $23.91M | - |
| Net Income | $80.69M | - | $52.41M | $50.96M | $28.47M | - | $15.62M | $21.22M | $49.14M | - |
| EPS - Basic | $0.51 | - | $0.33 | $0.33 | $0.18 | - | $0.10 | ($0.07) | $0.38 | - |
| EPS - Diluted | $0.50 | - | $0.32 | $0.31 | $0.17 | - | $0.10 | $0.16 | $0.38 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $247.98M | $197.02M | $355.67M | $294.17M | $287.51M | $157.67M | $69.09M | $38.16M | $73.42M | $58.27M |
| Accounts Receivable | $648.04M | $628.13M | $628.28M | $638.13M | $680.68M | $641.77M | $574.64M | $610.58M | $622.74M | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $180.66M | $192.23M | $205.48M | $172.02M | $198.62M | $175.06M | $154.74M | $125.75M | $140.95M | - |
| Current Assets | $1.07B | $1.07B | $1.13B | $1.08B | $1.08B | $938.26M | $734.78M | $800.65M | $722.15M | - |
| Total Assets | $5.66B | $5.58B | $5.63B | $5.50B | $5.49B | $5.24B | $4.52B | $3.90B | $3.51B | - |
| Current Liabilities | $1.07B | $1.00B | $1.20B | $1.17B | $1.11B | $978.43M | $681.72M | $468.10M | $531.55M | - |
| Long-term Debt | $239.81M | $244.80M | $245.90M | $246.99M | $249.09M | $250.98M | $253.65M | $227.11M | $230.85M | - |
| Total Liabilities | $4.62B | $4.63B | $4.75B | $4.69B | $4.74B | $4.53B | $3.85B | $3.32B | $3.41B | - |
| Stockholders' Equity | $1.04B | $946.77M | $871.32M | $806.84M | $750.23M | $709.55M | $660.05M | $572.13M | $96.13M | - |
| Retained Earnings | $390.27M | $309.58M | $249.88M | $197.47M | $146.51M | $118.04M | $80.83M | $100.50M | $96.00M | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $236.34M | - | - | - | $150.24M | - | - | - | $58.79M | - |
| Investing Cash Flow | ($126.96M) | - | - | - | ($16.42M) | - | - | - | ($118.67M) | - |
| Financing Cash Flow | ($67.71M) | - | - | - | ($4.07M) | - | - | - | $34.45M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | 17.2% | 39.8% | 21.3% | - |
| Operating margin | 8.5% | - | 6.4% | 6.1% | 3.8% | - | 3.5% | 0.1% | 8.6% | - |
| EBITDA margin | - | - | - | - | - | - | 4.2% | 0.7% | 9.4% | - |
| Net margin | 5.7% | - | 3.9% | 3.9% | 2.2% | - | 1.5% | 2.2% | 5.3% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 7.9% | - | 7.6% | 7.7% | 7.7% | - | 6.9% | 6.4% | 5.0% | - |
| Effective tax rate | 29.1% | - | 31.4% | 35.2% | 33.5% | - | 32.3% | 32.8% | 32.7% | - |
| Return on assets | 1.4% | - | 0.9% | 0.9% | 0.5% | - | 0.3% | 0.5% | 1.4% | - |
| Return on equity | 7.8% | - | 6.0% | 6.3% | 3.8% | - | 2.4% | 3.7% | 51.1% | - |
| Return on invested capital | 6.7% | - | 5.3% | 5.0% | 3.2% | - | 2.7% | 0.1% | 16.4% | - |
| Liquidity | ||||||||||
| Current ratio | 0.99 | 1.07 | 0.94 | 0.92 | 0.98 | 0.96 | 1.08 | 1.71 | 1.36 | - |
| Quick ratio | 0.99 | 1.07 | 0.94 | 0.92 | 0.98 | 0.96 | 1.08 | 1.71 | 1.36 | - |
| Cash ratio | 0.23 | 0.20 | 0.30 | 0.25 | 0.26 | 0.16 | 0.10 | 0.08 | 0.14 | - |
| Leverage | ||||||||||
| Debt / Equity | 0.23 | 0.26 | 0.28 | 0.31 | 0.33 | 0.35 | 0.38 | 0.40 | 2.40 | - |
| Debt / Assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | - |
| Debt / EBITDA | - | - | - | - | - | - | 5.93 | 33.06 | 2.63 | - |
| Interest coverage | 18.7x | - | 10.1x | 18.5x | 7.0x | - | 4.0x | 0.1x | - | - |
| Equity multiplier | 5.46 | 5.90 | 6.46 | 6.82 | 7.32 | 7.39 | 6.84 | 6.81 | 36.54 | - |
| Liabilities / Assets | 0.82 | 0.83 | 0.84 | 0.85 | 0.86 | 0.86 | 0.85 | 0.85 | 0.97 | - |
| Efficiency | ||||||||||
| Asset turnover | 0.25 | - | 0.24 | 0.24 | 0.23 | - | 0.23 | 0.25 | 0.27 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 167d | - | 171d | 178d | 195d | - | 204d | 227d | 243d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | 66d | 78d | 70d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 64.2x | - | 42.9x | 41.7x | 66.1x | - | 399.7x | 184.4x | - | - |
| P / B | 5.0x | - | 2.6x | 2.6x | 2.5x | - | 9.6x | 6.6x | - | - |
| P / S | 3.7x | - | 1.7x | 1.6x | 1.5x | - | 6.2x | 3.9x | - | - |
| EV / EBITDA | - | - | - | - | - | - | 152.4x | 580.3x | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 11.2% | - | 31.0% | 33.3% | 36.6% | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 149.3% | - | 137.0% | 11237.9% | -39.8% | - | - | - | - | - |
| Net income growth (YoY) | 183.4% | - | 235.5% | 140.2% | -42.1% | - | - | - | - | - |
| EPS growth (YoY) | 194.1% | - | 220.0% | 93.8% | -55.3% | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 38.2% | 33.4% | 32.0% | 41.0% | 680.5% | - | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$5.29B totalReportable Segment$5.29B · 100.0%
Peer comparison
Same SIC group: Services-Skilled Nursing Care Facilities
Comparing PACS Group against the 3 most active filers in the same SIC group.